Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Paracelsian Inc (PRLN) -- Ignore unavailable to you. Want to Upgrade?

To: FreedomForAll who wrote (4291)	12/20/1999 12:42:00 PM
From: John H. Farro	Read Replies (1) \| Respond to of 4342

Paracelsian and ExtractsPlus Sign BioFIT Letter of Intent ITHACA, NY, Dec. 20 /PRNewswire/ -- Paracelsian, Inc. (OTC Bulletin Board: PRLN - news), Ithaca, NY, paracelsian.com and ExtractsPlus, Carlsbad, CA, extractsplus.com announced today that they have signed a Letter of Intent aimed at implementing the use of Paracelsian's BioFIT® ''functional'' quality assurance program, along with the distinctive ''BioFIT Certified Bioactive'' logo in conjunction with the development, marketing and sale of the ExtractsPlus line of herbal products. The Letter of Intent calls for the completion of a formal Agreement within 90 days. ExtractsPlus is the North American distributor for Emil Flachsmann AG of Zurich, Switzerland, one of the acknowledged premiere suppliers of herbal extracts in the world. Flachsmann has been producing pharmaceutical quality botanical extracts for more than 50 years. ExtractsPlus hasbeen involved in the development of the market for high quality herbal extracts so the consumer will be assured of value in their purchase of finishedproducts. The BioFIT® ''functional'' quality assurance program (U.S. Patent Pending) provides a unique way to validate the label claims of herbal products by guaranteeing biological activity, in mechanisms associated with the product's benefit claim, that is equal to or better than that seen with a clinically tested reference product. Since, in the case of herbal products, chemical analysis alone has proven to be an inadequate predictor of biological activity, BioFIT® offers consumers a new, better way to differentiate from among the countless product offerings available to them. ExtractsPlus President, Bill Roberts, commented, ''We believe that the BioFIT® quality assurance program is the ultimate statement about the quality of herbal extracts. It answers the question, 'Does it work?' Since many finished herbal extract products are manufactured in the unregulated quality climate of the United States, it is very common for extracts to be produced under less than rigorous quality standards, and are even adulterated or mis-identified.'' Roberts added. ''This program will bring new standards that are long overdue in this country. Consumers should be able to trust the fact that they are getting the quality that they deserve,'' he concluded. Responding to Mr. Robert's comments, Paracelsian President and CEO Bernie Landes stated, ''We are looking forward to having ExtractsPlus join the exclusive group of BioFIT® certified raw material suppliers.'' ''Through BioFIT, ExtractsPlus will be able to further distinguish its superior quality herbal products from lower quality products seeking to claim equivalent value. It further confirms Paracelsian's conviction that a new era of quality assurance for herbal products has dawned in which consumers will be able to easily determine which of the myriad products on the shelf can back up their label claims,'' he added. ''We now look forward to a rapid proliferation of BioFIT® Certified products throughout the dietary supplement market, with those made from ExtractsPlus BioFIT® Certified Bioactive(TM) raw materials leading the way,'' he concluded. Paracelsian is a unique biotechnology company with two primary areas of focus. Paracelsian develops functional bioassays that are the basis of its BioFIT® Quality Assurance program for herbs, botanicals and other dietary supplements and the basis of its patented AhImmunoassy® used to monitor dioxins in food, water, soil and incinerator ash. In addition, Paracelsian's Internet business leverages extensive relationships in China and expertise in cutting edge plant-based nutritional science to provide unique content and related products, along with a variety of research and development services. Notice: This news release may contain forward-looking statements. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including but not limited to, the results of research and development efforts, the effect of regulation by the United States Food and Drug Administration and other agencies, the impact of competitive products, product development, commercialization and technological difficulties, and other risks detailed in the Company's periodic reports filed with the Securities and Exchange Commission. No forward-looking statement is a guarantee of future results or events, and one should avoid placing undue reliance on such statements. SOURCE: Paracelsian, Inc.